Tenofovir amibufenamide
Tenofovir amibufenamide (HS-10234) is an orally active prodrug of tenofovir, developed for chronic hepatitis B (CHB) research. It demonstrates potent antiviral activity against HBV in both in vitro and in vivo preclinical studies, supporting its investigation as a therapeutic candidate.
Product Specifications
CAS Number
1571076-26-0
Product Name Alternative
HS10234, HS-10234, HS 10234, HBV, Tenofovir amibufenamide
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
99.19% (May vary between batches)
Solubility
DMSO:180 mg/mL (366.98 mM)
Smiles
C ([C@H] (OCP (OC1=CC=CC=C1) (NC (C (OC (C) C) =O) (C) C) =O) C) N2C=3C (N=C2) =C (N) N=CN3
Molecular Formula
C22H31N6O5P
Molecular Weight
490.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472085-100 1x 100 µL
TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471779-100 1x 100 µL
CD8A (Cytotoxic- & Suppressor T-Cell Marker) (C8/1779R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details